Q BioMed Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 6/28/2017
Contact Info
  • c/o Ortoli Rosenstadt LLP
  • 501 Madison Avenue
  • 14th Floor
  • New York, NY 10022

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report May 31, 2017 10-Q
CIK 0001596062
Fiscal Year End 11/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2014
Employees 1 a/o Nov 30, 2014
Company Officers/Contacts
Denis Corin President, Consultant
Ari Jatwes Business Analyst
Company Directors
Denis Corin
William S. Rosenstadt
Company Notes
  • Formerly=ISMO Tech Solutions, Inc. until 7-2015
Service Providers
Accounting/Auditing Firm
Marcum LLP
750 Third Ave
11th Floor
New York, NY, 10017
United States

Legal Counsel
Ortoli Rosenstadt LLP
501 Madison Avenue
14th Floor
New York, NY, 10022
United States

Investor Relations Firm
Not Available
QBIO Security Details
Share Structure
Market Value1 $45,639,791 a/o Sep 21, 2017
Authorized Shares 250,000,000 a/o Sep 01, 2017
Outstanding Shares 11,496,169 a/o Sep 01, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 4,999,835 a/o Nov 30, 2016
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders of Record 4,200 a/o Jun 28, 2017
Short Selling Data
Short Interest 51,323 (3.77%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security